Industry Research Reports

Home > Reports > Pharma & Healthcare > Retinal Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Retinal Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 101 Pages

Report ld: 2340167

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Retinal drugs are the medications that are used for the treatment of retinal diseases
The global market for Retinal Drugs was estimated to be worth US$ 24080 million in 2023 and is forecast to a readjusted size of US$ 34670 million by 2030 with a CAGR of 5.3% during the forecast period 2024-2030

Retinal Drugs Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Retinal Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Retinal Drugs by region & country, by Type, and by Application.

The Retinal Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinal Drugs.

Market Segmentation

Report Metric
Details
Report Title
Retinal Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 34670 million
CAGR(2024-2030)
5.3%
Market Size Available for Years
2019-2030
Global Retinal Drugs Companies Covered
Bayer, F. Hoffmann-La Roche, Novartis, Regeneron, Merck, Takeda, Teva Pharmaceutical, ThromboGenics
Global Retinal Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Retinal Drugs Market, Segment by Type
Wet AMD

Diabetic Retinopathy

DME

RVO

Mcnv
Global Retinal Drugs Market, Segment by Application
Hospitial

Clinicl

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Retinal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Retinal Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Retinal Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Retinal Drugs Product Introduction
    1.2 Global Retinal Drugs Market Size Forecast
        1.2.1 Global Retinal Drugs Sales Value (2019-2030)
        1.2.2 Global Retinal Drugs Sales Volume (2019-2030)
        1.2.3 Global Retinal Drugs Sales Price (2019-2030)
    1.3 Retinal Drugs Market Trends & Drivers
        1.3.1 Retinal Drugs Industry Trends
        1.3.2 Retinal Drugs Market Drivers & Opportunity
        1.3.3 Retinal Drugs Market Challenges
        1.3.4 Retinal Drugs Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Retinal Drugs Players Revenue Ranking (2023)
    2.2 Global Retinal Drugs Revenue by Company (2019-2024)
    2.3 Global Retinal Drugs Players Sales Volume Ranking (2023)
    2.4 Global Retinal Drugs Sales Volume by Company Players (2019-2024)
    2.5 Global Retinal Drugs Average Price by Company (2019-2024)
    2.6 Key Manufacturers Retinal Drugs Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Retinal Drugs Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Retinal Drugs
    2.9 Retinal Drugs Market Competitive Analysis
        2.9.1 Retinal Drugs Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Retinal Drugs Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Drugs as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Wet AMD
        3.1.2 Diabetic Retinopathy
        3.1.3 DME
        3.1.4 RVO
        3.1.5 Mcnv
    3.2 Global Retinal Drugs Sales Value by Type
        3.2.1 Global Retinal Drugs Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Retinal Drugs Sales Value, by Type (2019-2030)
        3.2.3 Global Retinal Drugs Sales Value, by Type (%) (2019-2030)
    3.3 Global Retinal Drugs Sales Volume by Type
        3.3.1 Global Retinal Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Retinal Drugs Sales Volume, by Type (2019-2030)
        3.3.3 Global Retinal Drugs Sales Volume, by Type (%) (2019-2030)
    3.4 Global Retinal Drugs Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitial
        4.1.2 Clinicl
        4.1.3 Others
    4.2 Global Retinal Drugs Sales Value by Application
        4.2.1 Global Retinal Drugs Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Retinal Drugs Sales Value, by Application (2019-2030)
        4.2.3 Global Retinal Drugs Sales Value, by Application (%) (2019-2030)
    4.3 Global Retinal Drugs Sales Volume by Application
        4.3.1 Global Retinal Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Retinal Drugs Sales Volume, by Application (2019-2030)
        4.3.3 Global Retinal Drugs Sales Volume, by Application (%) (2019-2030)
    4.4 Global Retinal Drugs Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Retinal Drugs Sales Value by Region
        5.1.1 Global Retinal Drugs Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Retinal Drugs Sales Value by Region (2019-2024)
        5.1.3 Global Retinal Drugs Sales Value by Region (2025-2030)
        5.1.4 Global Retinal Drugs Sales Value by Region (%), (2019-2030)
    5.2 Global Retinal Drugs Sales Volume by Region
        5.2.1 Global Retinal Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Retinal Drugs Sales Volume by Region (2019-2024)
        5.2.3 Global Retinal Drugs Sales Volume by Region (2025-2030)
        5.2.4 Global Retinal Drugs Sales Volume by Region (%), (2019-2030)
    5.3 Global Retinal Drugs Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Retinal Drugs Sales Value, 2019-2030
        5.4.2 North America Retinal Drugs Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Retinal Drugs Sales Value, 2019-2030
        5.5.2 Europe Retinal Drugs Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Retinal Drugs Sales Value, 2019-2030
        5.6.2 Asia Pacific Retinal Drugs Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Retinal Drugs Sales Value, 2019-2030
        5.7.2 South America Retinal Drugs Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Retinal Drugs Sales Value, 2019-2030
        5.8.2 Middle East & Africa Retinal Drugs Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Retinal Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Retinal Drugs Sales Value
        6.2.1 Key Countries/Regions Retinal Drugs Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Retinal Drugs Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Retinal Drugs Sales Value, 2019-2030
        6.3.2 United States Retinal Drugs Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Retinal Drugs Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Retinal Drugs Sales Value, 2019-2030
        6.4.2 Europe Retinal Drugs Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Retinal Drugs Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Retinal Drugs Sales Value, 2019-2030
        6.5.2 China Retinal Drugs Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Retinal Drugs Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Retinal Drugs Sales Value, 2019-2030
        6.6.2 Japan Retinal Drugs Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Retinal Drugs Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Retinal Drugs Sales Value, 2019-2030
        6.7.2 South Korea Retinal Drugs Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Retinal Drugs Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Retinal Drugs Sales Value, 2019-2030
        6.8.2 Southeast Asia Retinal Drugs Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Retinal Drugs Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Retinal Drugs Sales Value, 2019-2030
        6.9.2 India Retinal Drugs Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Retinal Drugs Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Company Information
        7.1.2 Bayer Introduction and Business Overview
        7.1.3 Bayer Retinal Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Bayer Retinal Drugs Product Offerings
        7.1.5 Bayer Recent Development
    7.2 F. Hoffmann-La Roche
        7.2.1 F. Hoffmann-La Roche Company Information
        7.2.2 F. Hoffmann-La Roche Introduction and Business Overview
        7.2.3 F. Hoffmann-La Roche Retinal Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 F. Hoffmann-La Roche Retinal Drugs Product Offerings
        7.2.5 F. Hoffmann-La Roche Recent Development
    7.3 Novartis
        7.3.1 Novartis Company Information
        7.3.2 Novartis Introduction and Business Overview
        7.3.3 Novartis Retinal Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Novartis Retinal Drugs Product Offerings
        7.3.5 Novartis Recent Development
    7.4 Regeneron
        7.4.1 Regeneron Company Information
        7.4.2 Regeneron Introduction and Business Overview
        7.4.3 Regeneron Retinal Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Regeneron Retinal Drugs Product Offerings
        7.4.5 Regeneron Recent Development
    7.5 Merck
        7.5.1 Merck Company Information
        7.5.2 Merck Introduction and Business Overview
        7.5.3 Merck Retinal Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Merck Retinal Drugs Product Offerings
        7.5.5 Merck Recent Development
    7.6 Takeda
        7.6.1 Takeda Company Information
        7.6.2 Takeda Introduction and Business Overview
        7.6.3 Takeda Retinal Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Takeda Retinal Drugs Product Offerings
        7.6.5 Takeda Recent Development
    7.7 Teva Pharmaceutical
        7.7.1 Teva Pharmaceutical Company Information
        7.7.2 Teva Pharmaceutical Introduction and Business Overview
        7.7.3 Teva Pharmaceutical Retinal Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Teva Pharmaceutical Retinal Drugs Product Offerings
        7.7.5 Teva Pharmaceutical Recent Development
    7.8 ThromboGenics
        7.8.1 ThromboGenics Company Information
        7.8.2 ThromboGenics Introduction and Business Overview
        7.8.3 ThromboGenics Retinal Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 ThromboGenics Retinal Drugs Product Offerings
        7.8.5 ThromboGenics Recent Development

 8 Industry Chain Analysis
    8.1 Retinal Drugs Industrial Chain
    8.2 Retinal Drugs Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Retinal Drugs Sales Model
        8.5.2 Sales Channel
        8.5.3 Retinal Drugs Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Retinal Drugs Market Trends
    Table 2. Retinal Drugs Market Drivers & Opportunity
    Table 3. Retinal Drugs Market Challenges
    Table 4. Retinal Drugs Market Restraints
    Table 5. Global Retinal Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Retinal Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Retinal Drugs Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Retinal Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Retinal Drugs Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Retinal Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Retinal Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Retinal Drugs
    Table 13. Global Retinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Retinal Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Retinal Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Retinal Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Retinal Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Retinal Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Retinal Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Retinal Drugs Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Retinal Drugs Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Retinal Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Retinal Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Retinal Drugs Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Retinal Drugs Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Retinal Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Retinal Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Retinal Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Retinal Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Retinal Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Retinal Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Retinal Drugs Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Retinal Drugs Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Retinal Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Retinal Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Retinal Drugs Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Retinal Drugs Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Retinal Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Retinal Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Retinal Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Retinal Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Retinal Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Retinal Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Retinal Drugs Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Retinal Drugs Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Retinal Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Retinal Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Retinal Drugs Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Retinal Drugs Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Retinal Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Retinal Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Retinal Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Retinal Drugs Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Retinal Drugs Sales Volume, (2025-2030) & (K Units)
    Table 57. Bayer Company Information
    Table 58. Bayer Introduction and Business Overview
    Table 59. Bayer Retinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Bayer Retinal Drugs Product Offerings
    Table 61. Bayer Recent Development
    Table 62. F. Hoffmann-La Roche Company Information
    Table 63. F. Hoffmann-La Roche Introduction and Business Overview
    Table 64. F. Hoffmann-La Roche Retinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. F. Hoffmann-La Roche Retinal Drugs Product Offerings
    Table 66. F. Hoffmann-La Roche Recent Development
    Table 67. Novartis Company Information
    Table 68. Novartis Introduction and Business Overview
    Table 69. Novartis Retinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Novartis Retinal Drugs Product Offerings
    Table 71. Novartis Recent Development
    Table 72. Regeneron Company Information
    Table 73. Regeneron Introduction and Business Overview
    Table 74. Regeneron Retinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. Regeneron Retinal Drugs Product Offerings
    Table 76. Regeneron Recent Development
    Table 77. Merck Company Information
    Table 78. Merck Introduction and Business Overview
    Table 79. Merck Retinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Merck Retinal Drugs Product Offerings
    Table 81. Merck Recent Development
    Table 82. Takeda Company Information
    Table 83. Takeda Introduction and Business Overview
    Table 84. Takeda Retinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Takeda Retinal Drugs Product Offerings
    Table 86. Takeda Recent Development
    Table 87. Teva Pharmaceutical Company Information
    Table 88. Teva Pharmaceutical Introduction and Business Overview
    Table 89. Teva Pharmaceutical Retinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Teva Pharmaceutical Retinal Drugs Product Offerings
    Table 91. Teva Pharmaceutical Recent Development
    Table 92. ThromboGenics Company Information
    Table 93. ThromboGenics Introduction and Business Overview
    Table 94. ThromboGenics Retinal Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. ThromboGenics Retinal Drugs Product Offerings
    Table 96. ThromboGenics Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Retinal Drugs Downstream Customers
    Table 100. Retinal Drugs Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Retinal Drugs Product Picture
    Figure 2. Global Retinal Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Retinal Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Retinal Drugs Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Retinal Drugs Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Retinal Drugs Report Years Considered
    Figure 7. Global Retinal Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Retinal Drugs Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Retinal Drugs Revenue in 2023
    Figure 10. Retinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Wet AMD Picture
    Figure 12. Diabetic Retinopathy Picture
    Figure 13. DME Picture
    Figure 14. RVO Picture
    Figure 15. Mcnv Picture
    Figure 16. Global Retinal Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Retinal Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Global Retinal Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 19. Global Retinal Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 20. Global Retinal Drugs Price by Type (2019-2030) & (USD/Unit)
    Figure 21. Product Picture of Hospitial
    Figure 22. Product Picture of Clinicl
    Figure 23. Product Picture of Others
    Figure 24. Global Retinal Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Retinal Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Retinal Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 27. Global Retinal Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Retinal Drugs Price by Application (2019-2030) & (USD/Unit)
    Figure 29. North America Retinal Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Retinal Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Retinal Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Retinal Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Retinal Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Retinal Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Retinal Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Retinal Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Retinal Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Retinal Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Retinal Drugs Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Retinal Drugs Sales Volume (%), (2019-2030)
    Figure 41. United States Retinal Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Retinal Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Retinal Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Retinal Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Retinal Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Retinal Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Retinal Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Retinal Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Retinal Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Retinal Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Retinal Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Retinal Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Retinal Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Retinal Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Retinal Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Retinal Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Retinal Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Retinal Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Retinal Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Retinal Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Retinal Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 62. Retinal Drugs Industrial Chain
    Figure 63. Retinal Drugs Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed

Description

Retinal drugs are the medications that are used for the treatment of retinal diseases
The global market for Retinal Drugs was estimated to be worth US$ 24080 million in 2023 and is forecast to a readjusted size of US$ 34670 million by 2030 with a CAGR of 5.3% during the forecast period 2024-2030

Market Segmentation